Posterior reversible encephalopathy syndrome, preeclampsia or stroke? A diagnostic dilemma

BMJ Case Rep. 2019 Jul 27;12(7):e230281. doi: 10.1136/bcr-2019-230281.

Abstract

When a pregnant woman presents with headaches, visual disturbances, epigastric pain and nausea, preeclampsia quickly springs to mind. This case describes a primigravid 22-year-old female of 32 weeks gestation who presented with the symptoms described but was found to be apparently normotensive. Due to ongoing symptoms and diagnostic uncertainty in the absence of definitive evidence of preeclampsia, the patient was further investigated with an MRI brain scan, which was reported as either an acute stroke or an atypical presentation of posterior reversible encephalopathy syndrome. Together with blood results that showed heterozygosity for Factor V Leiden, we concluded that while the patient's clinical diagnosis was certainly preeclampsia, her investigations also supported an unexpected diagnosis of silent brain infarction. This report outlines a diagnostic dilemma that required multidisciplinary working between obstetricians, neurologists, radiologists and stroke physicians to manage the patient who went on to make a full recovery and deliver a healthy baby.

Keywords: haematology (incl blood transfusion); obstetrics and gynaecology; pregnancy; stroke.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / etiology*
  • Adrenergic beta-Antagonists / therapeutic use
  • Aspirin / therapeutic use
  • Diagnosis, Differential
  • Factor V
  • Female
  • Headache
  • Humans
  • Labetalol / therapeutic use
  • Nausea
  • Platelet Aggregation Inhibitors / therapeutic use
  • Posterior Leukoencephalopathy Syndrome / diagnosis*
  • Pre-Eclampsia / diagnosis*
  • Pre-Eclampsia / drug therapy
  • Pre-Eclampsia / physiopathology
  • Pregnancy
  • Pregnancy Complications / diagnosis*
  • Pregnancy Complications / physiopathology
  • Stroke / diagnosis*
  • Stroke / drug therapy
  • Stroke / physiopathology
  • Treatment Outcome
  • Young Adult

Substances

  • Adrenergic beta-Antagonists
  • Platelet Aggregation Inhibitors
  • factor V Leiden
  • Factor V
  • Aspirin
  • Labetalol